drugset / Trial / NCT02169427

An Open-label Study in Healthy Male Subjects to Assess the Absorption, Distribution, Metabolism and Excretion of [14C]-Labelled BIA 9-1067 and Metabolites

NCT02169427 ↗

Phase 1 Completed 6 enrolled Bial - Portela C S.A.
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to determine the rate and routes of excretion of OPC and the mass balance in urine, faeces and expired air.

Timeline

Start
2011-03
Primary completion
2011-07
Completion
2011-07

Drugs

EvaluationDrugModalityDoseRoute
Subject OPC Unknown 100 mg Oral

Indications